Published in Cell Mol Life Sci on May 15, 2011
Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov (2011) 4.16
The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation. Int J Mol Sci (2011) 1.23
In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms. Antimicrob Agents Chemother (2012) 1.07
Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides. Antimicrob Agents Chemother (2014) 1.00
Peptide design for antimicrobial and immunomodulatory applications. Biopolymers (2013) 0.99
Comparing selection on S. aureus between antimicrobial peptides and common antibiotics. PLoS One (2013) 0.91
Nylon-3 polymers with selective antifungal activity. J Am Chem Soc (2013) 0.91
Antimicrobial peptide GL13K is effective in reducing biofilms of Pseudomonas aeruginosa. Antimicrob Agents Chemother (2013) 0.90
A novel dendrimeric peptide with antimicrobial properties: structure-function analysis of SB056. Biophys J (2012) 0.90
Adaptive evolution of Escherichia coli to an α-peptide/β-peptoid peptidomimetic induces stable resistance. PLoS One (2013) 0.90
Host-defense peptides with therapeutic potential from skin secretions of frogs from the family pipidae. Pharmaceuticals (Basel) (2014) 0.88
Direct and indirect antimicrobial activities of neuropeptides and their therapeutic potential. Curr Protein Pept Sci (2012) 0.88
In vitro evaluation of the potential for resistance development to ceragenin CSA-13. J Antimicrob Chemother (2012) 0.87
Guanidino groups greatly enhance the action of antimicrobial peptidomimetics against bacterial cytoplasmic membranes. Biochim Biophys Acta (2014) 0.87
Post-translational Modifications of Natural Antimicrobial Peptides and Strategies for Peptide Engineering. Curr Biotechnol (2012) 0.86
From design to screening: a new antimicrobial peptide discovery pipeline. PLoS One (2013) 0.86
Exploring the pharmacological potential of promiscuous host-defense peptides: from natural screenings to biotechnological applications. Front Microbiol (2011) 0.84
New horizons for host defense peptides and lantibiotics. Curr Opin Pharmacol (2012) 0.84
Increased survival of experimentally evolved antimicrobial peptide-resistant Staphylococcus aureus in an animal host. Evol Appl (2014) 0.84
New role for human α-defensin 5 in the fight against hypervirulent Clostridium difficile strains. Infect Immun (2014) 0.83
Epinecidin-1 has immunomodulatory effects, facilitating its therapeutic use in a mouse model of Pseudomonas aeruginosa sepsis. Antimicrob Agents Chemother (2014) 0.83
Cationic antimicrobial peptide LL-37 is effective against both extra- and intracellular Staphylococcus aureus. Antimicrob Agents Chemother (2012) 0.83
Antimicrobial peptidomimetics: reinterpreting nature to deliver innovative therapeutics. Front Immunol (2012) 0.82
The novel antimicrobial peptide PXL150 in the local treatment of skin and soft tissue infections. Appl Microbiol Biotechnol (2012) 0.82
Human host defense peptide LL-37 stimulates virulence factor production and adaptive resistance in Pseudomonas aeruginosa. PLoS One (2013) 0.82
Coleopteran antimicrobial peptides: prospects for clinical applications. Int J Microbiol (2012) 0.81
Efficacy of the novel topical antimicrobial agent PXL150 in a mouse model of surgical site infections. Antimicrob Agents Chemother (2014) 0.81
Antifungal Activity of the Noncytotoxic Human Peptide Hepcidin 20 against Fluconazole-Resistant Candida glabrata in Human Vaginal Fluid. Antimicrob Agents Chemother (2013) 0.81
Antimicrobial peptides and wound healing: biological and therapeutic considerations. Exp Dermatol (2016) 0.80
A technology for developing synbodies with antibacterial activity. PLoS One (2013) 0.80
Isomerization of an antimicrobial peptide broadens antimicrobial spectrum to gram-positive bacterial pathogens. PLoS One (2012) 0.80
Mode of action and membrane specificity of the antimicrobial peptide snakin-2. PeerJ (2016) 0.80
Chitosan nanoparticles loaded with the antimicrobial peptide temporin B exert a long-term antibacterial activity in vitro against clinical isolates of Staphylococcus epidermidis. Front Microbiol (2015) 0.80
Anti-antimicrobial peptides: folding-mediated host defense antagonists. J Biol Chem (2013) 0.80
Killing of staphylococci by θ-defensins involves membrane impairment and activation of autolytic enzymes. Antibiotics (Basel) (2014) 0.80
pH Dependence of microbe sterilization by cationic antimicrobial peptides. Antimicrob Agents Chemother (2013) 0.79
Antimicrobial activity and molecular mechanism of the CRES protein. PLoS One (2012) 0.79
Microbicidal effects of α- and θ-defensins against antibiotic-resistant Staphylococcus aureus and Pseudomonas aeruginosa. Innate Immun (2013) 0.79
Temporins A and B stimulate migration of HaCaT keratinocytes and kill intracellular Staphylococcus aureus. Antimicrob Agents Chemother (2014) 0.79
Defensins and LL-37: a review of function in the gingival epithelium. Periodontol 2000 (2013) 0.79
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents. Front Cell Infect Microbiol (2016) 0.79
Guanidylation and tail effects in cationic antimicrobial lipopeptoids. PLoS One (2012) 0.78
Initial insights into structure-activity relationships of avian defensins. J Biol Chem (2011) 0.78
A Defensin from the Model Beetle Tribolium castaneum Acts Synergistically with Telavancin and Daptomycin against Multidrug Resistant Staphylococcus aureus. PLoS One (2015) 0.78
A Novel RNase 3/ECP Peptide for Pseudomonas aeruginosa Biofilm Eradication That Combines Antimicrobial, Lipopolysaccharide Binding, and Cell-Agglutinating Activities. Antimicrob Agents Chemother (2016) 0.78
Ultrashort cationic lipopeptides and lipopeptoids selectively induce cytokine production in macrophages. PLoS One (2013) 0.78
ATP synthase: a molecular therapeutic drug target for antimicrobial and antitumor peptides. Curr Med Chem (2013) 0.78
Antimicrobial Peptides Targeting Gram-Positive Bacteria. Pharmaceuticals (Basel) (2016) 0.77
Lipopolysaccharide Biosynthesis Genes of Yersinia pseudotuberculosis Promote Resistance to Antimicrobial Chemokines. PLoS One (2016) 0.77
Cm-p5: an antifungal hydrophilic peptide derived from the coastal mollusk Cenchritis muricatus (Gastropoda: Littorinidae). FASEB J (2015) 0.77
Antimicrobial host defensins - specific antibiotic activities and innate defense modulation. Front Immunol (2012) 0.77
Three-dimensional NMR structure of Hen Egg Gallin (Chicken Ovodefensin) reveals a new variation of the β-defensin fold. J Biol Chem (2014) 0.76
Anti-candidal activity of genetically engineered histatin variants with multiple functional domains. PLoS One (2012) 0.76
A hybrid cationic peptide composed of human β-defensin-1 and humanized θ-defensin sequences exhibits salt-resistant antimicrobial activity. Antimicrob Agents Chemother (2014) 0.76
The Poplar Rust-Induced Secreted Protein (RISP) Inhibits the Growth of the Leaf Rust Pathogen Melampsora larici-populina and Triggers Cell Culture Alkalinisation. Front Plant Sci (2016) 0.76
Adsorption of cationic peptides to solid surfaces of glass and plastic. PLoS One (2015) 0.76
IL-1β-Induced Protection of Keratinocytes against Staphylococcus aureus-Secreted Proteases Is Mediated by Human β-Defensin 2. J Invest Dermatol (2016) 0.75
β-defensins and the epididymis: contrasting influences of prenatal, postnatal, and adult scenarios. Asian J Androl (2016) 0.75
Antibacterial Low Molecular Weight Cationic Polymers: Dissecting the Contribution of Hydrophobicity, Chain Length and Charge to Activity. RSC Adv (2016) 0.75
Identification of Synthetic and Natural Host Defense Peptides with Leishmanicidal Activity. Antimicrob Agents Chemother (2016) 0.75
Sarkosyl-Induced Helical Structure of an Antimicrobial Peptide GW-Q6 Plays an Essential Role in the Binding of Surface Receptor OprI in Pseudomonas aeruginosa. PLoS One (2016) 0.75
In vitro and in vivo antibacterial effect of NZ2114 against Streptococcus suis type 2 infection in mice peritonitis models. AMB Express (2017) 0.75
Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide. PLoS One (2014) 0.75
Antitumor and antimicrobial activity of some cyclic tetrapeptides and tripeptides derived from marine bacteria. Mar Drugs (2015) 0.75
Identification of cell-penetrating peptides that are bactericidal to Neisseria meningitidis and prevent inflammatory responses upon infection. Antimicrob Agents Chemother (2013) 0.75
Glycin-rich antimicrobial peptide YD1 from B. amyloliquefaciens, induced morphological alteration in and showed affinity for plasmid DNA of E. coli. AMB Express (2017) 0.75
Treatment of Oral Biofilms by a D-Enantiomeric Peptide. PLoS One (2016) 0.75
Characterization of antibacterial and hemolytic activity of synthetic pandinin 2 variants and their inhibition against Mycobacterium tuberculosis. PLoS One (2014) 0.75
Antimicrobial and anti-inflammatory activities of three chensinin-1 peptides containing mutation of glycine and histidine residues. Sci Rep (2017) 0.75
Interaction of aurein 1.2 and its analogue with DPPC lipid bilayer. J Biol Phys (2017) 0.75
Position-Dependent Influence of the Three Trp Residues on the Membrane Activity of the Antimicrobial Peptide, Tritrpticin. Antibiotics (Basel) (2014) 0.75
Virucidal activity of Haemaphysalis longicornis longicin P4 peptide against tick-borne encephalitis virus surrogate Langat virus. Parasit Vectors (2016) 0.75
Protective role of the neuropeptide urocortin II against experimental sepsis and leishmaniasis by direct killing of pathogens. J Immunol (2013) 0.75
Cationic Acrylate Oligomers Comprising Amino Acid Mimic Moieties Demonstrate Improved Antibacterial Killing Efficiency. J Mater Chem B Mater Biol Med (2016) 0.75
D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung Infection. Front Chem (2017) 0.75
Screening of antimicrobials from Caribbean sea animals and isolation of bactericidal proteins from the littoral mollusk Cenchritis muricatus. Curr Microbiol (2012) 0.75
Studies of the antitumor mechanism of action of dermaseptin B2, a multifunctional cationic antimicrobial peptide, reveal a partial implication of cell surface glycosaminoglycans. PLoS One (2017) 0.75
Antiviral Activity of Ctn[15-34], A Cathelicidin-Derived Eicosapeptide, Against Infectious Myonecrosis Virus in Litopenaeus vannamei Primary Hemocyte Cultures. Food Environ Virol (2017) 0.75
Innate defense regulator IDR-1018 activates human mast cells through G protein-, phospholipase C-, MAPK- and NF-ĸB-sensitive pathways. Immunol Res (2017) 0.75
β-defensins: An innate defense for bovine mastitis. Vet World (2017) 0.75
A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Sci Rep (2017) 0.75
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc (2008) 7.92
Peptide antimicrobial agents. Clin Microbiol Rev (2006) 6.04
Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res (2010) 5.23
PSICQUIC and PSISCORE: accessing and scoring molecular interactions. Nat Methods (2011) 5.01
Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev Cell (2002) 4.94
InnateDB: facilitating systems-level analyses of the mammalian innate immune response. Mol Syst Biol (2008) 4.61
Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov (2011) 4.16
Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol (2011) 3.49
Cerebral: a Cytoscape plugin for layout of and interaction with biological networks using subcellular localization annotation. Bioinformatics (2007) 3.39
Protein interaction data curation: the International Molecular Exchange (IMEx) consortium. Nat Methods (2012) 3.17
Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol Microbiol (2003) 3.06
Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa. Genome Res (2008) 3.03
Recognition of host immune activation by Pseudomonas aeruginosa. Science (2005) 2.84
Pseudomonas Genome Database: facilitating user-friendly, comprehensive comparisons of microbial genomes. Nucleic Acids Res (2008) 2.71
Cationic host defense (antimicrobial) peptides. Curr Opin Immunol (2005) 2.71
InnateDB: systems biology of innate immunity and beyond--recent updates and continuing curation. Nucleic Acids Res (2012) 2.66
Pseudomonas aeruginosa Genome Database and PseudoCAP: facilitating community-based, continually updated, genome annotation. Nucleic Acids Res (2005) 2.61
The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol (2002) 2.57
Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin. Chem Biol (2004) 2.51
The relationship between peptide structure and antibacterial activity. Peptides (2003) 2.51
Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J Exp Med (2002) 2.40
Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. Biochim Biophys Acta (2006) 2.35
Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol (2006) 2.32
Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog Dis (2013) 2.32
Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J Biol Chem (2005) 2.28
Construction of a mini-Tn5-luxCDABE mutant library in Pseudomonas aeruginosa PAO1: a tool for identifying differentially regulated genes. Genome Res (2005) 2.22
Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis. MBio (2012) 2.15
Peptide arrays on cellulose support: SPOT synthesis, a time and cost efficient method for synthesis of large numbers of peptides in a parallel and addressable fashion. Nat Protoc (2007) 2.08
Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev Anti Infect Ther (2007) 2.06
ArrayPipe: a flexible processing pipeline for microarray data. Nucleic Acids Res (2004) 2.03
High-throughput generation of small antibacterial peptides with improved activity. Nat Biotechnol (2005) 2.01
Impact of LL-37 on anti-infective immunity. J Leukoc Biol (2004) 2.01
Swarming of Pseudomonas aeruginosa is a complex adaptation leading to increased production of virulence factors and antibiotic resistance. J Bacteriol (2008) 1.98
An anti-infective peptide that selectively modulates the innate immune response. Nat Biotechnol (2007) 1.97
The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol (2009) 1.92
Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa. FEMS Microbiol Rev (2009) 1.91
Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun (2008) 1.91
Can innate immunity be enhanced to treat microbial infections? Nat Rev Microbiol (2004) 1.90
Sequence requirements and an optimization strategy for short antimicrobial peptides. Chem Biol (2006) 1.84
Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2005) 1.82
The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol (2004) 1.78
The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A. Antimicrob Agents Chemother (2011) 1.78
A re-evaluation of the role of host defence peptides in mammalian immunity. Curr Protein Pept Sci (2005) 1.78
Genome-wide identification of Pseudomonas aeruginosa exported proteins using a consensus computational strategy combined with a laboratory-based PhoA fusion screen. Genome Res (2005) 1.77
Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS. Antimicrob Agents Chemother (2010) 1.74
Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin Microbiol Rev (2012) 1.74
Using microarray gene signatures to elucidate mechanisms of antibiotic action and resistance. Drug Discov Today (2005) 1.74
Immune modulation by multifaceted cationic host defense (antimicrobial) peptides. Nat Chem Biol (2013) 1.73
Evidence that plant-like genes in Chlamydia species reflect an ancestral relationship between Chlamydiaceae, cyanobacteria, and the chloroplast. Genome Res (2002) 1.72
Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob Agents Chemother (2002) 1.69
Immunomodulatory activities of small host defense peptides. Antimicrob Agents Chemother (2005) 1.67
Complex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibility. Antimicrob Agents Chemother (2008) 1.67
Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells. J Immunol (2011) 1.65
Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. Curr Opin Microbiol (2013) 1.63
Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide. Antimicrob Agents Chemother (2012) 1.63
Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages. PLoS One (2009) 1.61
Aminoglycoside efflux in Pseudomonas aeruginosa: involvement of novel outer membrane proteins. Antimicrob Agents Chemother (2003) 1.59
AMPer: a database and an automated discovery tool for antimicrobial peptides. Bioinformatics (2007) 1.59
Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol (2009) 1.58
Identification of genes involved in swarming motility using a Pseudomonas aeruginosa PAO1 mini-Tn5-lux mutant library. J Bacteriol (2006) 1.54
Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides. Biopolymers (2008) 1.51
Characterization of a proteolytically stable multifunctional host defense peptidomimetic. Chem Biol (2013) 1.49
Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations. Vaccine (2011) 1.48
INMEX--a web-based tool for integrative meta-analysis of expression data. Nucleic Acids Res (2013) 1.48
Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrob Agents Chemother (2005) 1.44
The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J Immunol (2004) 1.41
Intracellular receptor for human host defense peptide LL-37 in monocytes. J Immunol (2009) 1.38
Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS-independent activation of NF-kappa B. Eur J Immunol (2007) 1.37
Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways. J Immunol (2007) 1.37
The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect Immun (2008) 1.36
Genetic determinants involved in the susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics. Antimicrob Agents Chemother (2010) 1.35
Cationic peptides: distribution and mechanisms of resistance. Curr Pharm Des (2002) 1.35
Enabling a systems biology approach to immunology: focus on innate immunity. Trends Immunol (2009) 1.35
Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptides. J Biol Chem (2007) 1.33
Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. ACS Chem Biol (2009) 1.33
Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment. J Immunol (2010) 1.32
Curating the innate immunity interactome. BMC Syst Biol (2010) 1.30
Permeabilization of fungal hyphae by the plant defensin NaD1 occurs through a cell wall-dependent process. J Biol Chem (2010) 1.28
Systems-level comparison of host responses induced by pandemic and seasonal influenza A H1N1 viruses in primary human type I-like alveolar epithelial cells in vitro. Respir Res (2010) 1.26
Fluorescent probes alter miscibility phase boundaries in ternary vesicles. J Phys Chem B (2007) 1.26
The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. J Leukoc Biol (2006) 1.25
Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect Immun (2005) 1.24
Structural studies of a peptide with immune modulating and direct antimicrobial activity. Chem Biol (2010) 1.24
Antimicrobial properties of lactoferrin. Biochimie (2008) 1.24
Creeping baselines and adaptive resistance to antibiotics. Drug Resist Updat (2011) 1.24
Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2008) 1.24
ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease. Clin Immunol (2008) 1.23
Identification of novel antibacterial peptides by chemoinformatics and machine learning. J Med Chem (2009) 1.23
The global access initiative at the University of British Columbia (UBC): Availability of UBC discoveries and technologies to the developing world. J Pharm Sci (2009) 1.23
The sensor kinase PhoQ mediates virulence in Pseudomonas aeruginosa. Microbiology (2009) 1.23
Role of the novel OprD family of porins in nutrient uptake in Pseudomonas aeruginosa. J Bacteriol (2006) 1.22
Swarming of Pseudomonas aeruginosa is controlled by a broad spectrum of transcriptional regulators, including MetR. J Bacteriol (2009) 1.21
The Lon protease of Pseudomonas aeruginosa is induced by aminoglycosides and is involved in biofilm formation and motility. Microbiology (2007) 1.21
Comparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides. Chem Biol Drug Des (2006) 1.20
The role of sphingosine-1-phosphate transporter Spns2 in immune system function. J Immunol (2012) 1.20
Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother (2009) 1.19
ProbeLynx: a tool for updating the association of microarray probes to genes. Nucleic Acids Res (2004) 1.17
Effect of divalent cations on the structure of the antibiotic daptomycin. Eur Biophys J (2007) 1.17
Cathelicidins and functional analogues as antisepsis molecules. Expert Opin Ther Targets (2007) 1.16